<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT03163030</url>
  </required_header>
  <id_info>
    <org_study_id>C-04</org_study_id>
    <nct_id>NCT03163030</nct_id>
  </id_info>
  <brief_title>Autonomic Regulation Therapy in Heart Failure With Preserved Ejection Fraction</brief_title>
  <official_title>Autonomic Neural Regulation Therapy to Enhance Myocardial Function in Heart Failure With Preserved Ejection Fraction (ANTHEM-HFpEF) Study</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Cyberonics, Inc.</agency>
      <agency_class>Industry</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Cyberonics, Inc.</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      The ANTHEM-HFpEF Study is designed to demonstrate the safety and efficacy of vagus nerve
      stimulation (VNS) with the Cyberonics VNS Therapy System for the treatment of subjects with
      symptomatic heart failure with preserved and mid-range ejection fraction.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Heart failure patients will be enrolled and implanted with a cervical VNS system on the right
      side. After a 2-week post-implantation recovery period and a 10-week stimulation titration
      period, continuous periodic stimulation will be performed for 12 months, with data collection
      at 3, 6, 9, and 12 months.
    </textblock>
  </detailed_description>
  <overall_status>Recruiting</overall_status>
  <start_date>August 2014</start_date>
  <completion_date type="Anticipated">December 2018</completion_date>
  <primary_completion_date type="Anticipated">December 2017</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <intervention_model>Single Group Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Adverse Events</measure>
    <time_frame>12 months</time_frame>
    <description>Incidence of procedure and device-related complications</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Cardiac Size (LAVI)</measure>
    <time_frame>12 months</time_frame>
    <description>Left atrial volume index</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Functional Status (6MWD)</measure>
    <time_frame>12 months</time_frame>
    <description>6-minute walk distance</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Quality of Life</measure>
    <time_frame>12 months</time_frame>
    <description>Minnesota Living with Heart Failure Questionnaire score</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Functional Status (NYHA Class)</measure>
    <time_frame>12 months</time_frame>
    <description>New York Heart Association classification</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Cardiac Function (E/E')</measure>
    <time_frame>12 months</time_frame>
    <description>Ratio of mitral velocity to early diastolic velocity of the mitral annulus</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Cardiac Size (LV mass index)</measure>
    <time_frame>12 months</time_frame>
    <description>Left ventricular mass index</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Autonomic Function (HRV)</measure>
    <time_frame>12 months</time_frame>
    <description>Heart rate variability</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Blood Biomarkers</measure>
    <time_frame>12 months</time_frame>
    <description>Blood Levels of Heart Failure Biomarkers (NT-proBNP, creatinine, C-reactive protein)</description>
  </secondary_outcome>
  <number_of_arms>1</number_of_arms>
  <enrollment type="Anticipated">50</enrollment>
  <condition>Congestive Heart Failure</condition>
  <arm_group>
    <arm_group_label>Therapy</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Right Cervical Vagus Nerve Stimulation (VNS)</description>
  </arm_group>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>Vagus Nerve Stimulation (VNS)</intervention_name>
    <description>Electrical Stimulation of the Vagus Nerve</description>
    <arm_group_label>Therapy</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

        Patients with symptomatic heart failure, New York Heart Association (NYHA) class II/III
        with preserved and mid-range EF (â‰¥40%).

        Exclusion Criteria:
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Imad Libbus, Ph.D</last_name>
    <role>Study Director</role>
    <affiliation>Cyberonics, Inc.</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Bryan Olin</last_name>
    <phone>281-228-7223</phone>
    <email>bryan.olin@cyberonics.com</email>
  </overall_contact>
  <location>
    <facility>
      <name>Krishna Institute of Medical Science</name>
      <address>
        <city>Secunderabad</city>
        <country>India</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Rajendra Kumar Premchand, MD</last_name>
      <email>kumarpre@hotmail.com</email>
    </contact>
  </location>
  <location_countries>
    <country>India</country>
  </location_countries>
  <verification_date>May 2017</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>May 19, 2017</study_first_submitted>
  <study_first_submitted_qc>May 19, 2017</study_first_submitted_qc>
  <study_first_posted type="Actual">May 22, 2017</study_first_posted>
  <last_update_submitted>May 19, 2017</last_update_submitted>
  <last_update_submitted_qc>May 19, 2017</last_update_submitted_qc>
  <last_update_posted type="Actual">May 22, 2017</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>Heart Failure</keyword>
  <keyword>Preserved Ejection Fraction</keyword>
  <keyword>VNS</keyword>
  <keyword>Vagus Nerve</keyword>
  <keyword>Autonomic Regulation Therapy</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Heart Failure</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

